Neutron capture therapy of epidermal growth factor (+) gliomas using boronated cetuximab (IMC-C225) as a delivery agent
Authors:
- Rolf F BarthRBRolf F Barth
- Gong WuGWGong Wu
- Weilian YangWYWeilian Yang
- Peter J BinnsPBPeter J Binns
- Kent J RileyKRKent J Riley
- Hemant PatelHPHemant Patel
- Jeffrey A CoderreJCJeffrey A Coderre
- Werner TjarksWTWerner Tjarks
- A.K BandyopadhyayaABA.K Bandyopadhyaya
- B.T.S ThirumamagalBTB.T.S Thirumamagal
- Michael J CiesielskiMCMichael J Ciesielski
- Robert A FenstermakerRFRobert A Fenstermaker
- 1 November 2004
- journal article
- Published by Elsevier in Applied Radiation and Isotopes
- Vol. 61 (5) , 899-903
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Combination of boron neutron capture therapy and external beam radiotherapy for brain tumorsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2004
- Site-Specific Conjugation of Boron-Containing Dendrimers to Anti-EGF Receptor Monoclonal Antibody Cetuximab (IMC-C225) and Its Evaluation as a Potential Delivery Agent for Neutron Capture TherapyBioconjugate Chemistry, 2003
- Evaluation of Systemically Administered Radiolabeled Epidermal growth Factor as a Brain Tumor Targeting AgentJournal of Neuro-Oncology, 2001
- Mixed field dosimetry of epithermal neutron beams for boron neutron capture therapy at the MITR‐II research reactorMedical Physics, 1994
- Determination of boron in tissues and cells using direct-current plasma atomic emission spectroscopyAnalytical Chemistry, 1991